ZEPOSIA 360 SUPPORT Trademark

Trademark Overview


On Wednesday, November 20, 2019, a trademark application was filed for ZEPOSIA 360 SUPPORT with the United States Patent and Trademark Office. The USPTO has given the ZEPOSIA 360 SUPPORT trademark a serial number of 88700173. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, October 2, 2020. This trademark is owned by Celgene Corporation. The ZEPOSIA 360 SUPPORT trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Administration of patient reimbursement programs in connection ozanimod; administering pharmacy reimbursement programs and services in connection ozanimod

Medical information and counseling in the field of ozanimod and safety issues pertaining to ozanimod, and providing medical information in connection with ozanimod, multiple sclerosis (RMS) and ulcerative colitis (UC) by distributing written materials in connection therewith; providing a web site featuring medical information on ozanimod, multiple sclerosis (RMS) and ulcerative colitis (UC); providing an internet website for medical professionals and medical patients featuring medical information on ozanimod, multiple sclerosis (RMS) and ulcerative colitis (UC); providing information relating to diagnostic, prophylactic and therapeutic properties of ozanimod; providing medical information, consultancy and advisory service in connection with ozanimod, multiple sclerosis (RMS) and ulcerative colitis (UC)
zeposia 360 support

General Information


Serial Number88700173
Word MarkZEPOSIA 360 SUPPORT
Filing DateWednesday, November 20, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, October 2, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAdministration of patient reimbursement programs in connection ozanimod; administering pharmacy reimbursement programs and services in connection ozanimod
Goods and ServicesMedical information and counseling in the field of ozanimod and safety issues pertaining to ozanimod, and providing medical information in connection with ozanimod, multiple sclerosis (RMS) and ulcerative colitis (UC) by distributing written materials in connection therewith; providing a web site featuring medical information on ozanimod, multiple sclerosis (RMS) and ulcerative colitis (UC); providing an internet website for medical professionals and medical patients featuring medical information on ozanimod, multiple sclerosis (RMS) and ulcerative colitis (UC); providing information relating to diagnostic, prophylactic and therapeutic properties of ozanimod; providing medical information, consultancy and advisory service in connection with ozanimod, multiple sclerosis (RMS) and ulcerative colitis (UC)
Pseudo MarkZEPOSIA THREE HUNDRED SIXTY SUPPORT; ZEPOSIA THREE SIX ZERO SUPPORT; ZEPOSIA THREE SIXTY SUPPORT

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, November 27, 2019
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 27, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events


Event DateEvent Description
Friday, October 2, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, October 2, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, March 21, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, March 21, 2020FINAL REFUSAL E-MAILED
Saturday, March 21, 2020FINAL REFUSAL WRITTEN
Wednesday, February 26, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 26, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 26, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 6, 2020NON-FINAL ACTION E-MAILED
Monday, January 6, 2020NON-FINAL ACTION WRITTEN
Monday, December 30, 2019ASSIGNED TO EXAMINER
Wednesday, November 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 23, 2019NEW APPLICATION ENTERED IN TRAM